Tag Archives: cancer immunotherapy

Leidos Earns US Patent for Peptide-Based Treatment for Cancer, Infectious Diseases

TYSONS CORNER, VA, January 8, 2018 — The Leidos (NYSE: LDOS) life sciences business unit has been awarded a patent for peptide-based PD-1 checkpoint inhibitors via the U.S. Patent and Trademark Office‘s accelerated application review process for cancer immunotherapy-related discoveries, ExecutiveBiz reported Friday. The company said Thursday the Leidos Health Life Sciences team …

Read More »